Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_assertion description "[Mesothelin, a glycosylphosphatidylinositol (GPI) anchored cell surface protein, is a potential target for antibody-based cancer therapy due to its high expression in mesothelioma, ovarian cancer, pancreatic cancer, cholangiocarcinoma and other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_assertion evidence source_evidence_literature NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_assertion SIO_000772 22721387 NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_assertion wasDerivedFrom befree-2016 NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_assertion wasGeneratedBy ECO_0000203 NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.
- befree-2016 importedOn "2016-02-19" NP991927.RAlNQco9sTe3fd_UyPQQa7w2PsFZq_BLC-ilO1yUKZryk130_provenance.